Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-006119
Filing Date
2025-02-12
Accepted
2025-02-12 16:01:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5816
  Complete submission text file 0001493152-25-006119.txt   7389
Mailing Address 17300 EL CAMINEO REAL, SUITE 110 HOUSTON TX 77058
Business Address
O'HEERON PETE (Filed by) CIK: 0001569334 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Subject) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94820 | Film No.: 25614688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)